Skip to main content
Equibles
EUDA logo

EUDA · EUDA Health Holdings Ltd

Track EUDA — free

Use EUDA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EUDA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$17.30 +0.06 (+0.37%) At close · Oct 5
Rebalance outlook locked
Going-concern doubt — flagged Jul 31, 2023

Substantial doubt about the company's ability to continue as a going concern.

“management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that these unaudited condensed consolidated financial statements are issued.”
View the 10-Q filed Jul 31, 2023
Market Cap
$51.80M
Shares
2.99M
Volume · Oct 5 6037 Avg daily vol (3M) 14.19K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$17.30 Open$17.29 Day$16.99–17.85 52W close$5.26–77.80 Avg vol 30d25K Short int2K · 0.1% float · 1.0d Short vol63% Last earningsAug 13, 2026 DataDec 2021–Oct 2026 Filing10-Q · Jul 31

Up next

Next earnings call
Oct 8, 2026 Est · unconfirmed · this week
Latest filing: 10-Q
filed Jul 31, 2023

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-36.3%
Year over year
Operating margin
-36.3%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+118.2%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −10%
below
Price vs 50-day avg +10%
above
RSI (14) 56
neutral
MACD trend Negative
52-week position 17%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +28%
trailing
6-month return +116%
trailing
YTD return −63%
this year
Relative strength +104%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $16 › 200d $19 — 200d above 50d
Institutional flow Distributing
-11% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.05% of float · ▼ -38.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
8 holders — near 3-yr low, contrarian setup
Squeeze score 43
elevated · 0–100
Fundamentals
Strong
Revenue growth +70%
Y/Y
Gross margin 44%
expanding
EPS growth +84%
Y/Y
Free cash flow $-2.5M
Quant / Vol
risk profile
Very High
Volatility 181%
annualized · 1-yr
Max drawdown −93%
past year
ATR 8.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−10% Bearish
Price vs 50-day avg
+10% Bullish
RSI (14)
56 Neutral
MACD trend
Negative Bearish
52-week position
17% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $16 › 200d $19 — 200d above 50d
Institutional flow Distributing
-11% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.05% of float · ▼ -38.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
8 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $5 Now $17 · 17% Range high $78
vs 200-day avg -10% vs 50-day avg +10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Real Estate Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
EUDA
EUDA Health Holdings Ltd
this stock
$51.80M — +70.0% — 0.1%
CBRE
Cbre Group, Inc.
 $37.89B -19.5% +13.4% 30.1 1.5%
SURDF
Sumitomo Realty & Development Co., Ltd./ADR
 $19.05B -24.5% — — 0.1%
BEKE
KE Holdings Inc.
 $18.26B +4.7% +5.6% — 1.9%
JLL
Jones Lang Lasalle Inc
 $14.81B -10.1% +11.4% 15.4 2.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
8
% held
26.6%
Net QoQ
-108.1K sh
Top holder
LMR Partners LLP
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
1.6K
Days to cover
1.0d
Change
-972 sh
View
Short Volume
Short vol %
63%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
628
Value
$8.2K
As of
Sep 11, 2026
View
Off-Exchange
Off-exchange %
43.2%
Week of
Aug 31, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$6.8M
Net income (FY)
$-2.8M
EPS diluted
$-1.48
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 29, 2026
This year
17
View
Exempt Offerings
Offering
$4.0M
Filed
May 31, 2023
View
Earnings & Events
Webcasts
Last webcast
Sep 22, 2026
View

Performance

5D 20D 120D MTD YTD
EUDA +6.8% +28.2% +115.7% +21.0% -62.6%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY +5.6% +27.6% +104.1% +19.4% -76.2%
Key facts CIK 1847846 CUSIP G3142E147 Visit website Investor relations